Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01900236 · ClinicalTrials.gov registry record · NA
Integrating ENGagement and Adherence Goals Upon Entry iENGAGE to Control HIV
A NA study, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- NA
- Development phase
- 371
- Enrollment target
NCT01900236 is a NA study that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 371 participants.
The verdict
NCT01900236, a NA study, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- NA
- Development phase
- 371 participants
- Enrollment target
Study Summary
iENGAGE is a 4 session, in-clinic behavioral intervention that is delivered to new clinic patients during the first year of HIV care on a flexible delivery schedule, with intervention visits scheduled to coincide with HIV medical care visits. Interventionists from each participating collaborating site will be trained centrally to implement the iENGAGE protocol. Following study enrollment and baseline assessment, participants will be randomized to treatment as usual and intervention groups. For intervention-arm participants, each iENGAGE intervention session includes: interventionist-delivered educational content for managing HIV medical care appointment-keeping and information sessions for learning to manage HIV medications. The intervention will have a tailored, interactive agenda for each of the 4 sessions based on behavioral motivational interviewing (MI) techniques. The goal of this intervention is for the participant to establish early behaviors that help him/her to arrive at scheduled medical appointments and learn to take medications as prescribed during the initial year of HIV care in order to improve overall health.
Interventions
- BEHAVIORAL Based on behavioral motivational interviewing (MI) technique
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 371 participants |
| Start Date | 2013-12 |
| Est. Completion | 2018-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01900236
The ClinicalTrials.gov registry entry for NCT01900236 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 371 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Based on behavioral motivational interviewing (MI) technique is the first listed.
NCT01900236 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01900236 about?
NCT01900236 is a clinical study titled "Integrating ENGagement and Adherence Goals Upon Entry iENGAGE to Control HIV". iENGAGE is a 4 session, in-clinic behavioral intervention that is delivered to new clinic patients during the first year of HIV care on a flexible delivery schedule, with intervention visits scheduled to coincide with HIV medical care visits. Interventionists from each participating collaborating si...
What is the current status of trial NCT01900236?
This trial is currently completed. It is a NA study. The enrollment target is 371 participants. The study started on 2013-12. Estimated completion is 2018-12.
What interventions are being tested in trial NCT01900236?
The interventions under investigation include: Based on behavioral motivational interviewing (MI) technique (BEHAVIORAL).
Who is sponsoring clinical trial NCT01900236?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.